{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:21:13Z","timestamp":1787840473052,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"\n Background:<\/jats:title>\n Chronic kidney disease (CKD) is capital-intensive and challenging to manage, thus, a need for a cost-effective and accessible marker. Monocyte lymphocyte ratio (MLR), a subset of leukocytes, is valuable as a surrogate tool of chronic systemic inflammation in evaluating and assessing CKD stages and complications. Elevated MLR is associated with worsening systemic inflammation and immune dysfunction in CKD.<\/jats:p>\n <\/jats:sec>\n \n Aim:<\/jats:title>\n To determine whether increase in MLR correlates with progression in CKD stages.<\/jats:p>\n <\/jats:sec>\n \n Subject and Methods:<\/jats:title>\n \n Evaluate the relationship between the MLR and CKD stages. Cross-sectional. Tertiary care centre in Lagos, Nigeria. This is a cross-sectional study of 300 patients with CKD attending a teaching hospital in Lagos, Nigeria, conducted between January 2024 and July 2024. The patients\u2019 CKD stages were evaluated using the modification of diet in renal disease to calculate their estimated glomerular filtration rate with their corresponding MLR retrieved from their full blood count results. The data were analysed using the SPSS software version 23.0. The statistical significance was set at a\n P<\/jats:italic>\n < 0.05.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n The mean age was 58.5 (5.7) with a male-female ratio of 1.6:1. The average MLR was 0.44 (0.14) the correlation between CKD stages and MLR was (\n r<\/jats:italic>\n = 0.763,\n P<\/jats:italic>\n = 0.001) subjects in CKD 2 and 3 compared to those on dialysis were 27.4 times likely to fall in fourth quartile of MLR.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Our study revealed that elevated MLR, an inflammatory marker, was strongly associated with worsening renal function across all CKD stages.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/npmj.npmj_278_24","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:00:58Z","timestamp":1761544858000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Monocyte-lymphocyte-ratios, Changes of Patterns in Different Stages of Chronic Kidney Disease, Risks and Progression"],"prefix":"10.4103","volume":"32","author":[{"given":"Mumuni Alade","family":"Amisu","sequence":"first","affiliation":[{"name":"Department of Medicine, Nephrology Unit, Ikeja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotubo","family":"Sotomiwa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology Unit, Lagos State University Teaching Hospital, Ikeja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adegboyega","family":"Kayode","sequence":"additional","affiliation":[{"name":"Department of Radiology, Endocrinology Unit, Ikeja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dada","family":"Akinola","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology Unit, Ikeja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogundele","family":"Sunday","sequence":"additional","affiliation":[{"name":"Department of Basic Clinical Sciences, Clinical Pharmacology, Lagos State University College of Medicine, Ikeja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odeyemi","family":"Ayoola","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology Unit, Lagos State University Teaching Hospital, Ikeja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okundia","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Bio-statistics, University of Lagos, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"R1-20251027","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"R2-20251027","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: A comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Front Immunol"},{"key":"R3-20251027","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1159\/000519289","article-title":"Increased monocyte\/lymphocyte ratio as risk marker for cardiovascular events and infectious disease hospitalization in dialysis patients","volume":"51","author":"Muto","year":"2022","journal-title":"Blood Purif"},{"key":"R4-20251027","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5455\/jabet.2024.d29","article-title":"Association of monocyte-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and tumor necrosis factor \u2013 \u03b1 in various stages of chronic kidney disease","volume":"7","author":"Sari","year":"2024","journal-title":"J Adv Biotechnol Exp Ther"},{"key":"R5-20251027","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2019.11.021","article-title":"Monocyte lymphocyte ratio predicts the new-onset of chronic kidney disease: A cohort study","volume":"503","author":"Zhang","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R6-20251027","doi-asserted-by":"crossref","first-page":"e12813","DOI":"10.1097\/MD.0000000000012813","article-title":"Association of lymphocyte to monocyte ratio with severity of coronary artery disease","volume":"97","author":"Gong","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R7-20251027","doi-asserted-by":"crossref","first-page":"7911033","DOI":"10.1155\/2022\/7911033","article-title":"The role of the monocyte-to-lymphocyte ratio in acute ischemic stroke patients with acute kidney injury","volume":"2022","author":"Jiang","year":"2022","journal-title":"Mediators Inflamm"},{"key":"R8-20251027","doi-asserted-by":"crossref","first-page":"657","DOI":"10.34067\/KID.0007922021","article-title":"Association of monocyte count and monocyte\/lymphocyte ratio with the risk of cardiovascular outcomes in patients with CKD","volume":"3","author":"Oh","year":"2022","journal-title":"Kidney360"},{"key":"R9-20251027","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","article-title":"Monocyte in coronary artery disease and atherosclerosis: Where are we now?","volume":"62","author":"Ghattas","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R10-20251027","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1445-5994.2011.02500.x","article-title":"Association between serum cystatin C, monocytes and other inflammatory markers","volume":"42","author":"Evangelopoulos","year":"2012","journal-title":"Intern Med J"},{"key":"R11-20251027","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.kint.2021.01.026","article-title":"Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification","volume":"99","author":"Mary","year":"2021","journal-title":"Kidney Int"},{"key":"R12-20251027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/jpm11030224","article-title":"Elevated monocyte to lymphocyte ratio and increased mortality among patients with chronic kidney disease hospitalized for COVID-19","volume":"11","author":"D\u00e1vila-Collado","year":"2021","journal-title":"J Pers Med"},{"key":"R13-20251027","doi-asserted-by":"crossref","first-page":"3239057","DOI":"10.1155\/2022\/3239057","article-title":"Role and mechanism of the renin-angiotensin-aldosterone system in the onset and development of cardiorenal syndrome","volume":"2022","author":"Ma","year":"2022","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R14-20251027","doi-asserted-by":"crossref","first-page":"117.7","DOI":"10.1186\/1471-2458-8-117","article-title":"Prevalence of chronic kidney disease in population-based studies: Systematic review","volume":"8","author":"Zhang","year":"2008","journal-title":"BMC Public Health"},{"key":"R15-20251027","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X221114807","article-title":"Hematological abnormalities and comorbidities are associated with the severity of kidney disease: A hospital-based cross-sectional study in Bangladesh","volume":"15","author":"Rahman","year":"2022","journal-title":"Clin Pathol"},{"key":"R16-20251027","doi-asserted-by":"crossref","first-page":"2352126","DOI":"10.1080\/0886022X.2024.2352126","article-title":"Association between monocyte-lymphocyte ratio and all-cause and cardiovascular mortality in patients with chronic kidney diseases: A data analysis from national health and nutrition examination survey (NHANES) 2003-2010","volume":"46","author":"Liu","year":"2024","journal-title":"Ren Fail"},{"key":"R17-20251027","doi-asserted-by":"crossref","first-page":"183","DOI":"10.23876\/j.krcp.20.163","article-title":"Implications of oxidative stress in chronic kidney disease: A review on current concepts and therapies","volume":"40","author":"Verma","year":"2021","journal-title":"Kidney Res Clin Pract"},{"key":"R18-20251027","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/cpr.14.46","article-title":"Chronic kidney disease in the elderly: Evaluation and management","volume":"11","author":"Mallappallil","year":"2014","journal-title":"Clin Pract (Lond)"},{"key":"R19-20251027","doi-asserted-by":"crossref","first-page":"7243523","DOI":"10.1155\/2021\/7243523","article-title":"Prevalence of chronic kidney disease as a marker of hypertension target organ damage in Africa: A systematic review and meta-analysis","volume":"2021","author":"Ajayi","year":"2021","journal-title":"Int J Hypertens"},{"key":"R20-20251027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12882-023-03109-1","article-title":"The prevalence of chronic kidney disease in South Africa \u2013 Limitations of studies comparing prevalence with Sub-Saharan Africa, Africa, and globally","volume":"24","author":"Hariparshad","year":"2023","journal-title":"BMC Nephrol"},{"key":"R21-20251027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"Carrero","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R22-20251027","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41371-023-00843-9","article-title":"Sex and gender differences in the management of chronic kidney disease and hypertension","volume":"37","author":"Mayne","year":"2023","journal-title":"J Hum Hypertens"},{"key":"R23-20251027","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MNH.0000000000000482","article-title":"Impact of gender and gender disparities in patients with kidney disease","volume":"28","author":"Brar","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R24-20251027","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3389\/fimmu.2018.02845","article-title":"Chronic kidney disease severity is associated with selective expansion of a distinctive intermediate monocyte subpopulation","volume":"9","author":"Naicker","year":"2018","journal-title":"Front Immunol"},{"key":"R25-20251027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5414\/CN109434","article-title":"Monocyte count modifies the association between chronic kidney disease and risk of death","volume":"90","author":"Koraishy","year":"2018","journal-title":"Clin Nephrol"},{"key":"R26-20251027","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s11255-014-0687-0","article-title":"Relative lymphocyte count as a marker of progression of chronic kidney disease","volume":"46","author":"Kim","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R27-20251027","first-page":"268","article-title":"Prevalence and associated factors of chronic kidney disease among patients infected with human immunodeficiency virus in Cameroon","volume":"12","author":"Marie","year":"2018","journal-title":"Iran J Kidney Dis"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_278_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:23:29Z","timestamp":1787837009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_278_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_278_24","relation":{},"ISSN":["1117-1936","2468-6875"],"issn-type":[{"value":"1117-1936","type":"print"},{"value":"2468-6875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2024-11-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}